Affomix Corporation

Harnessing advanced technology for swift, automated selection of human monoclonal antibodies for precise protein measurement in biological samples.

General Information
Company Name
Affomix Corporation
Founded Year
2006
Location (Offices)
Founders / Decision Makers
Number of Employees
-
Industries
Biotechnology, Health Care
Funding Stage
Series A
Social Media

Affomix Corporation - Company Profile

Affomix Corporation, founded in 2006, specializes in leveraging advanced technology for the swift, automated selection of human monoclonal antibodies. The company's mission is to bring proprietary mAbs, mAb microarrays, and mAb libraries to the market for various applications in research, drug discovery, diagnostics, and therapeutics within the Biotechnology and Health Care industries. Affomix focuses on the precise and sensitive measurement of extensive numbers of proteins in biological samples using their mAbs. The company received a notable $7.00M Series A investment on 22 February 2008 from a group of investors including Connecticut Innovations, Elm Street Ventures, and Four Seasons Ventures. With their commitment to cutting-edge technology and applications in the biotechnology and healthcare sectors, Affomix Corporation presents an intriguing opportunity for venture capitalists looking to invest in innovative solutions for protein measurement and antibody-based technologies.

Taxonomy: monoclonal antibodies, high-throughput selection, proprietary technology, drug discovery, diagnostics, therapeutics, protein measurement, mAb microarrays, biological samples, automated selection, commercialization, precision medicine, advanced technology

Funding Rounds & Investors of Affomix Corporation (1)

View All
Funding Stage Amount No. Investors Investors Date
Series A $7.00M 3 22 Feb 2008

Latest News of Affomix Corporation

View All

No recent news or press coverage available for Affomix Corporation.

Similar Companies to Affomix Corporation

View All
Arsanis - Similar company to Affomix Corporation
Arsanis Leading the fight against infectious diseases with advanced monoclonal antibody therapies.
GamaMabs Pharma - Similar company to Affomix Corporation
GamaMabs Pharma Advancing the future of immuno-oncology with innovative monoclonal antibody treatments
Surf Bio - Similar company to Affomix Corporation
Surf Bio Transforming the Delivery of Biologics
American Infusion Services - Similar company to Affomix Corporation
American Infusion Services Fight COVID with mAbs Monoclonal Antibody Treatment for COVID-19 At Home and for LTC facilities.
Galaxy Biotech, LLC - Similar company to Affomix Corporation
Galaxy Biotech, LLC Optimizing scientific potential by prioritizing well-documented targets and streamlining preclinical collaborations.